Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,644 | -47,350 | -50,500 | -61,850 | -50,601 |
| Depreciation Amortization | 9,580 | 8,875 | 7,884 | 6,410 | 4,393 |
| Accounts receivable | -4,105 | -5,584 | -878 | -1,555 | -2,250 |
| Accounts payable and accrued liabilities | 5,224 | 1,501 | -1,389 | 2,557 | 4,105 |
| Other Working Capital | -294 | -12,003 | -3,057 | -11,265 | 1,052 |
| Other Operating Activity | 14,373 | 19,635 | 15,428 | 12,281 | 7,664 |
| Operating Cash Flow | $6,134 | $-34,926 | $-32,512 | $-53,422 | $-35,637 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -78,733 | -80 | 36,522 | -19,593 | -15,623 |
| PPE Investments | -17,776 | -2,092 | -2,575 | -4,815 | -7,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -500 | -1,500 |
| Other Investing Activity | 0 | 0 | 0 | -500 | -1,500 |
| Investing Cash Flow | $-96,509 | $-2,172 | $33,947 | $-24,908 | $-24,123 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 70,000 | 7,098 | 15,000 | 10,000 |
| Debt Repayment | -57 | -35,093 | -92 | -7,848 | -40 |
| Common Stock Issued | 87,727 | 13,904 | 1,083 | 87,554 | 31,632 |
| Other Financing Activity | -100 | -3,638 | -20 | -5,656 | -1,233 |
| Financing Cash Flow | $87,570 | $45,173 | $8,069 | $89,050 | $40,359 |
| Exchange Rate Effect | -95 | -1 | 28 | 75 | -25 |
| Beginning Cash Position | 45,118 | 37,044 | 27,512 | 16,717 | 36,143 |
| End Cash Position | 42,218 | 45,118 | 37,044 | 27,512 | 16,717 |
| Net Cash Flow | $-2,900 | $8,074 | $9,532 | $10,795 | $-19,426 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,134 | -34,926 | -32,512 | -53,422 | -35,637 |
| Capital Expenditure | -17,776 | -2,092 | -2,575 | -4,815 | -7,000 |
| Free Cash Flow | -11,642 | -37,018 | -35,087 | -58,237 | -42,637 |